浅析肝炎后肝硬化和酒精性肝硬化患者临床特征

Analysis of Clinical Features of Posthepatitic Cirrhosis and Alcoholic Cirrhosis

目的研究分析肝硬化和酒精性肝硬化患者临床特征。方法选取我院接收的137例肝炎后肝硬化患者和82例酒精性肝硬化患者作为研究对象。对所有患者的基本资料、实验室检查结果、并发症情况进行对比分析。结果肝炎后肝硬化组中,GGT(63.8±10.2)U/L、AST/ALT(1.01±0.22)及ALP(119.6±25.3)U/L;酒精性肝硬化组中,GGT(139.4±47.9)U/L、AST/ALT(1.98±0.53)及ALP(215.7±46.5)U/L,组间数据对比,差异均具有统计学意义(P<0.05)。肝炎后肝硬化组中,肝肾综合征发生率为8.03%、原发性肝癌发生率为29.20%,酒精性肝硬化组分别为3.66%、9.76%,组间数据对比,差异均具有统计学意义(P<0.05)。结论肝炎后和酒精性肝硬化患者临床接受针对性预防治疗措施能够改善病情,效果显著。

Objective To investigate the clinical characteristics of cirrhosis and alcoholic cirrhosis. Methods 137 patients with posthepatitic cirrhosis and 82 patients with alcoholic cirrhosis were selected as the study subjects. The basic data, laboratory test results and complications of all patients were analyzed. Results In the posthepatitic cirrhosis group, GGT （63.8±10.2） U/L, AST/ALT （1.01±0.22） and ALP （119.6±25.3） U/L; In alcoholic liver cirrhosis group, GGT （139.4±47.9） U/L, AST/ALT （1.98±0.53） and ALP （215.7±46.5） U/L, the difference between the two groups was statistically significant （P〈0.05）. In the cirrhosis group, the incidence of hepatorenal syndrome was 8.03%, and the incidence of primary liver cancer was 29.20%, the alcoholic cirrhosis group was 3.66% and 9.76% respectively, the difference between the two groups was statistically significant （P 〈 0.05）. Conclusion After hepatitis and alcoholic cirrhosis, clinical targeted prevention and treatment measures can improve the disease, and the effect is better.